ARTICLE | Clinical News
Epogam and Efamast regulatory update
January 17, 2000 8:00 AM UTC
SOH said that the U.K.'s Committee on Safety of Medicines will review the company's Epogam and Efamast, which restore levels of gamma linoleic acid metabolites to treat atopic eczema and breast pain,...